Gilead and Moderna lead on coronavirus treatments
Saturday, March 7, 2020 - 06:40
in Health & Medicine
Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via